Pyrrolidine

Pyrrolidine

SCHEMBL4393172

C1CCNC1.CCCCCN1CCCCC1O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
GBA1 P04062 4/20 0.43
GNAO1 P09471 5/20 0.42
GNAI3 P08754 4/20 0.42
GNAI1 P63096 4/20 0.42
S1PR1 P21453 2/20 0.41
S1PR3 Q99500 2/20 0.41
S1PR5 Q9H228 2/20 0.41
S1PR4 O95977 1/20 0.40
GBA2 Q9HCG7 9/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2850065 0.90 S1PR1 (0.47) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL10590808 0.89 S1PR1 (0.49) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL3428819 0.89 S1PR1 (0.49) GBA1S1PR1S1PR3S1PR5S1PR4
Methane SCHEMBL6600535 0.87 S1PR1 (0.48) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL4229106 0.85 GBA2 (0.46) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL3265496 0.85 S1PR1 (0.50) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL28123990 0.79 GBA2 (0.47) GBA1S1PR1S1PR3S1PR5S1PR4
SCHEMBL27675556 0.77 GBA1 (0.43) GBA1S1PR1S1PR3S1PR5GAA
SCHEMBL3255618 0.75 GNAO1 (0.42) GBA1GNAO1GNAI3GNAI1S1PR1
SCHEMBL23865736 0.73 SPHK2 (0.58) GBA1S1PR1S1PR3S1PR5S1PR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099454-A2 AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS Abbott Laboratories (US) 2009-09-16 EP disclosed
CN-101534824-A Aminopyrrolidines as chemokine receptor antagonists ABBOTT LAB (US) 2009-09-16 CN disclosed
WO-2008060621-A2 AMINOPYRROLIDINES AS CHEMOKINE RECEPTOR ANTAGONISTS ABBOTT LABORATORIES (US) 2008-05-22 WO disclosed